| | The Coronary Flow Reserve Is Transiently Impaired in Tako-Tsubo Cardiomyopathy: A Prospective Study Using Serial Doppler Transthoracic Echocardiography published online 12 July 2007. The clinical features of tako-tsubo cardiomyopathy or transient left apical ballooning syndrome (LABS) have been clearly described, but the mechanisms are still unknown. Our objective was to prospectively assess coronary microcirculation at the acute phase of LABS and after functional recovery, using Doppler transthoracic echocardiography-coronary flow reserve (CFR). Twelve consecutive patients (11 women, mean age 68 ± 10 years) satisfying the criteria for LABS underwent Doppler transthoracic echocardiography-CFR in the distal part of the left anterior descending coronary artery, using intravenous adenosine infusion (0.14 mg/kg/min over 2 minutes) at the acute phase and 25 ± 3 days later. CFR was calculated as the ratio of hyperemic to basal mean diastolic flow velocity. Wall-motion score (WMS) was calculated using the 16-segment model during the same echocardiographic examination (normal WMS = 16). Doppler transthoracic echocardiography-CFR increased between the two examinations from 2.2 ± 0.4 at the acute phase to 2.9 ± 0.3 (P < .01), whereas WMS decreased (from 31 ± 6 at the acute phase to 16.5 ± 0.8, delta WMS = −14.6 ± 6, P < .01). All patients exhibited an increase of CFR between the two tests (delta CFR = 0.73 ± 0.39, range: 0.3-1.6). A significant correlation was observed between delta CFR and delta WMS (r = −0.89, P < .01). In conclusion, serial noninvasive CFR measurements performed in LABS suggested transient microcirculatory impairment during the acute phase of the syndrome. The wall-motion improvement parallel to the dynamic improvement of the microcirculation suggests a role of coronary microcirculatory damage in the pathogenesis of acute and transient wall-motion abnormalities in LABS. Transient left ventricular (LV) dysfunction involving the mid and apical portion of the LV wall with no flow-limiting obstruction on angiography is now well recognized since the first description by Dote et al1 in the early 1990s. It is called “tako-tsubo” because the afflicted LV resembles an octopus pot or transient left apical ballooning syndrome (LABS). However, although the clinical features of this syndrome are well described, typically affecting postmenopausal women who have experienced a physically or emotionally stressful event,2, 3, 4, 5, 6, 7, 8, 9 the mechanisms are still unknown. Exaggerated catecholamine release inducing myocardial stunning has been suggested.6, 7 However, the role of coronary microcirculation remains unclear.2, 3, 4 The studies that directly or indirectly assessed the coronary microcirculation in LABS were either invasive or used nuclear perfusion imaging.2, 3, 4, 10, 11, 12, 13, 14 The role of echocardiography is underused in this setting, only represented by case reports.15, 16, 17 Recent advances in Doppler transthoracic echocardiography (TTE) allow noninvasive evaluation of coronary flow and coronary flow reserve (CFR) with a high success rate, and previous studies have validated the feasibility and usefulness of TTE for noninvasive evaluation of CFR in various settings.18, 19, 20, 21, 22 We hypothesized that LABS may be related to acute transient microcirculatory damage that could be demonstrated by TTE, which allows serial noninvasive evaluation of the coronary blood flow at the patient’s bedside, at low cost.18, 19, 20, 21, 22 In the absence of epicardial coronary artery stenosis, blood flow velocities estimated in the middistal left anterior descending coronary artery (LAD) can be considered a reliable marker of coronary microcirculation.18, 19, 20, 21, 22, 23 To assess whether the microcirculation is involved in LABS, we, therefore, evaluated prospectively the CFR in the distal part of the LAD in 12 consecutives cases of LABS during the acute phase and after recovery, using TTE. Methods  Between September 2005 and January 2007, in a series of 850 patients undergoing coronary angiography for suspected acute coronary syndrome at our institution, 12 consecutive patients (11 female, mean age 68 ± 10 years) satisfying the criteria for LABS2, 3, 4, 5, 6, 7 and without contraindication to adenosine were prospectively included in the study. These 12 patients underwent standard echocardiographic examination and TTE-CFR in the distal part of the LAD during the acute phase of the syndrome (within 48 hours of symptom onset) and after 25 ± 3 days (range: 21-28 days), with commercially available machines (Sequoia 256 ultrasound system, Acuson, Mountain View, CA, and IE33 system, Philips, Amsterdam, The Netherlands). LABS was diagnosed according to the following classic criteria: acute chest pain or dyspnea, a stressful event, transient LV wall-motion abnormalities (WMA) at the apex of the ventricle, S-T segment elevation or T-wave inversion in the electrocardiogram (ECG), and no significant epicardial coronary stenosis on angiography (no luminal narrowing > 50% in all coronary arteries).8, 9 None of the patients in this series had a history of myocardial infarction, significant valvular heart disease, febrile, or acute neurologic disorders. Each patient gave informed consent to participate in the protocol. Coronary Angiography Selective coronary angiography was performed using standard techniques, during the acute phase of the syndrome in all patients (6 ± 3 hours after symptom onset) and demonstrated normal coronary anatomy in all but one patient. Patient 3 had an intermediate stenosis of the first diagonal branch (50%). However, this stenosis did not explain the extent of WMA observed during the acute phase and was not responsible for myocardial ischemia. LV angiography showed typical apical ballooning in all patients. The mean LV ejection fraction (EF) was 36 ± 8%. Echocardiography and CFR Each patient underwent standard echocardiography at admission, at least one repeated echocardiogram at 1 week (before discharge), and noninvasive CFR and quantification of LV function 48 hours after admission and 3 to 4 weeks after the onset in an outpatient visit. Noninvasive CFR was performed as previously described,20, 22 using intravenous adenosine infusion (0.14 μg/kg/min over 2 minutes). Briefly, the middistal part of the LAD was studied using a low multifrequency transducer (3V2C probe),20, 22 and the artery was visualized by color Doppler flow mapping guidance, in the modified parasternal view. For color Doppler echocardiography, the velocity range was defined from 12 to 16 cm/s. Blood flow velocity was measured by pulsed wave Doppler echocardiography, using a sample volume of 3 to 4 mm, placed on the color signal in the distal LAD. The ultrasound beam direction was aligned as closely as possible with the distal LAD flow. No angle correction was performed for the study given that CFR is the ratio between hyperemic and baseline flow velocity, and it is not affected by the actual flow velocity. However, the angle was kept as small as possible. CFR was calculated as the ratio of hyperemic to basal mean diastolic flow velocity. The spectral Doppler signal of LAD flow was recorded at an identical portion of the artery for a given patient on each examination. Blood flow velocity measurements were performed offline by an experienced investigator blinded to patient data, by contouring the spectral Doppler signals, using the integrated software package of the ultrasound system. Final values of flow velocity represented an average of 3 cardiac cycles. The interobserver and intraobserver variabilities for CFR measurements have been previously reported (around 5% and 4%, respectively).20, 22 LV EF and wall-motion score (WMS) using the 16-segment model24 were obtained during echocardiographic examination on the same day as the CFR evaluations. Wall motion in each of the 16 segments of the LV was scored from 1 (normal) to 4 (dyskinesia) (normal WMS = 16). WMS index (WMSI) was also obtained in each patient by dividing the WMS by the number of segments visualized (16 for each patient). LV EF was measured using the biplane Simpson’s rule. All echocardiograms were digitized online on optical disks for subsequent offline analysis by two other experienced observers blinded to patient data. A contrast agent (Sonovue, Bracco, Altana Pharma, Dijon, France) was used in 3 cases (25%) (patients 6, 7, and 11) to improve visualization of the color Doppler signal and/or to obtain clear spectral Doppler signals in the LAD and was administered intravenously at a concentration of 45 μg/mL, in a volume of 5 mL, as a 0.1-mL bolus. Statistics Values are expressed as mean ± SD with median in parentheses. Two-tailed Wilcoxon signed rank test was performed to compare the two time points. The relationship between various parameters was evaluated by Spearman’s rank correlation. To test variability of CFR, the between-measure of agreement25 was calculated in 10 stable volunteers without cardiomyopathy who gave informed consent to repeated CFR measurements 3 weeks apart. A P level less than .05 was considered statistically significant. Results  Each case is described in Table 1. Nine patients (75%) were hypertensive, 4 (33%) were treated for dyslipidemia, 3 (25%) were diabetic, and all but one were nonsmokers. The mean body mass index was 27 ± 6 kg/m2 (range: 18-38). A stressful event was identified in each case (emotional n = 10 and physical n = 2). Acute chest pain was the most common presenting symptom. Admission ECGs showed S-T elevation in precordial leads (patients 2, 4, 7, and 8), and in lateral leads (patient 12), slow R progression in precordial leads (patients 1, 10, and 12). There was T-wave inversion in precordial leads (patients 3, 5, 6, 8, 10, and 11) and left bundle branch block (patient 9). The mean QTc was 440 ± 34 milliseconds. Subsequent ECGs showed T-wave inversion at least in precordial leads in all patients. Subacute pulmonary edema that resolved rapidly (within a few hours), was observed in 3 cases on admission (patients 4, 7, and 8). Mechanical and hemodynamic support with intraaortic balloon conterpulsation was required for one patient for 36 hours (patient 12). No other complication occurred during the hospital stay. The mean peak troponin T was 0.6 ± 0.6 μg/L (normal < 0.05). The medications prescribed at discharge were left to the discretion of the physicians. A representative case is described in Figure 1. | | |  | | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | Case 8 | Case 9 | Case 10 | Case 11 | Case 12 |  |
|---|
 | Age, y | 73 | 71 | 54 | 75 | 69 | 74 | 51 | 78 | 65 | 54 | 76 (male) | 81 |  |  | Presenting symptoms | Chest pain | Chest pain | Chest pain | Chest pain, dyspnea | Chest pain | Chest pain | Chest pain, dyspnea | Chest pain, dyspnea | Chest pain | Chest pain | Chest pain, dyspnea | Chest pain, dyspnea |  |  | Stressful event | Emergency operation for her husband | Fear of planned operation | Quarrel with her boss, lost her job | Diagnosis of metastatic cancer for her daughter | Diagnosis of cancer for her daughter | Trauma while home alone | Exacerbated chronic stress (preparation of reception) | Quarrel with a relative | Fear of a threatening dog | Quarrel with her daughter-in-law | Exacerbated lung disease | Repeated annoyance and the strain of a long bus trip |  |  | WMS 1 | 31 | 35 | 37 | 17 | 33 | 36 | 24 | 33 | 26 | 30 | 35 | 36 |  |  | WMS 2 | 17 | 16 | 18 | 16 | 17 | 16 | 16 | 18 | 16 | 16 | 16 | 16 |  |  | CFR 1 | 2.15 | 2.1 | 2.4 | 2.7 | 2.2 | 2.6 | 2.8 | 2.1 | 1.8 | 2.4 | 1.85 | 1.3 |  |  | CFR 2 | 2.65 | 2.9 | 3.05 | 3 | 2.7 | 3.7 | 3.2 | 2.7 | 2.4 | 2.9 | 3.1 | 2.9 |  |  | Comorbidity | Hypertension, dyslipidemia | Hypertension, history of atrial flutter | Hypertension, diabetes, dyslipidemia | Hypertension | History of occasional palpitations | Depression | Hypertension | Dyslipidemia, hypertension | Hypertension | Hypertension, diabetes, smoking | Hypertension, lung disease | Hypertension, diabetes, dyslipidemia |  | | | |
In each patient, the initial TTE (performed 6 ± 4 hours within admission) revealed balloonlike LV WMA involving the apical and midsegments with hypercontraction of the basal segments of the LV, and normal LV cavity dimensions. No LV obstruction was observed except in one patient. At the acute phase, patient 5 presented systolic anterior motion of the mitral valve, and mild LV outflow tract obstruction unmasked after the Valsalva maneuver with a peak gradient at 44 mm Hg. Her mitral leaflets were thickened and she presented signs of mitral billowing and mild mitral regurgitation. After recovery, she did not exhibit any LV obstruction. Adenosine infusion was well tolerated and no serious adverse effect was observed during the two tests. TTE-CFR was performed with the patients in sinus rhythm. The first TTE-CFR was performed while LV WMA was still present in all but one patient who recovered very early (patient 4). Except for heart rate, no significant change of baseline hemodynamic variables was observed between the two examinations (Table 2). The results of coronary flow velocities and CFR in the whole population are described in Table 3 and the course of CFR and WMS for each patient (calculated during the same examination) is shown in Table 1. | ⁎ P < .05 vs baseline. †P < .05 vs acute phase. |
| ⁎ P < .01 vs baseline. †P < .01 vs acute phase. |
Resting coronary flow velocity did not vary significantly during follow-up, compared with the acute phase. A significant increase of hyperemic flow velocity was observed at follow-up, compared with the acute phase. A significant improvement of CFR was, therefore, observed between the two examinations (Figure 1). TTE-CFR increased from 2.2 ± 0.4 (median = 2.2) at the acute phase to 2.9 ± 0.3 (median = 2.9, P = .0005). All patients exhibited an increase of CFR between the two tests (delta CFR = 0.73 ± 0.4, range: 0.3-1.6) (Figure 2). The interval of agreement for repeated measures of CFR (second-first test) obtained in 10 volunteers was from −9% to +12%. The individual variation of CFR was considered significant when outside this interval of agreement. An increase exceeding 12% in the CFR after recovery was detected in all but one patient (patient 4) affected by LABS (mean increase 38%). LV systolic dysfunction and WMA rapidly reversed, returning to the normal range in all patients (Figure 1), as assessed by follow-up TTE 25 ± 3 days after admission, and as early as 48 hours for patient 4 with a history of a similar episode 2 months previously. Therefore, LV EF, assessed by echocardiography, increased from 40 ± 7% at the acute phase to 68 ± 5% at the chronic phase (P = .0005) and WMS decreased from 31 ± 6 at the acute phase to 16.5 ± 0.8 at the chronic phase (P = .0005) with delta WMS = −14.6 ± 6 (range: −20 to −1). Similarly, WMSI decreased from 1.93 ± 0.36 at the acute phase to 1.02 ± 0.05 (P < .01), delta WMSI = −0.9 ± 0.36. A significant correlation was observed between delta CFR and delta WMS (r = −0.89, P = .003), between delta CFR and delta WMSI (r = −0.88, P = .003), and between delta CFR and WMS and WMSI at the acute phase (r = 0.84, P = .005, and r = 0.92, P = .002, respectively) (Figure 3). Discussion  These 12 patients presented features of LABS: elderly women (11 of 12) with chest pain and reversible balloonlike LV WMA at the apex extending beyond the perfusion territory of a single coronary artery and sparing the basal segments, ST-T abnormalities on ECG, absence of major epicardial coronary artery narrowing on angiography, and a possible emotional or physical stress as a trigger.2, 3, 4, 5, 6, 7, 8, 9 They also presented no evidence of myocarditis, pheochromocytoma, or neurologic disorders suggestive of subarachnoid hemorrhage. A vasospastic mechanism can also be discussed: for patients 2, 4, 7, 8, and 12, the coronary angiogram performed during acute S-T elevation was normal, and the distribution of WMA at admission encompassed a single vessel territory. For the other patients, the initial ECG result argued against coronary spasm, which would be expected to be associated with immediate S-T elevation. The pathophysiology of LABS has not been clearly elucidated. An exaggerated transient catecholamine release giving rise to myocardial stunning in a predisposed myocardium has been postulated.6, 7 Sudden surges in circulating catecholamine levels could induce direct myocyte injury or microcirculatory damage or both, but the exact mechanism has not been identified. In this setting, the apex is thought to be more vulnerable than other regions.2 The earliest studies that have directly assessed the microcirculation in the setting of LABS provided conflicting results.2, 3, 4 In the study by Abe et al,4 3 patients were submitted to an invasive Doppler flow wire to evaluate the CFR at the middle portion of the LAD at the acute phase of the syndrome. The median value of CFR was 2.2 (range: 1.3-3.6). The authors concluded that no significant abnormality in the microcirculation was detected. However, because of its invasive nature, no subsequent CFR was performed during follow-up, particularly after recovery, and no definitive conclusions can be drawn concerning the CFR values obtained at the acute phase. Tsutchihashi et al2 described a patient with transient depression of CFR as assessed by nuclear cardiographic evaluations performed at the acute phase and 5 months later by positron emission computed tomography. Kurisu et al3 suggested that microvascular spasm could be one of the mechanisms of tako-tsubo. Bybee et al10 found that patients with LABS had significantly abnormal thrombolysis in myocardial infarction frame count, an index of coronary blood flow, compared with control subjects, and this abnormality involved all 3 major epicardial vessels in nearly two thirds of their patients (10 of 16). A recent study using a Doppler guidewire11 suggested transient coronary microcirculatory damage at the acute phase of the syndrome. Echocardiography is underused in this setting, represented only by few recent case reports using myocardial contrast echocardiography and TTE-CFR.15, 16, 17 Yet, because of the capacity of TTE to noninvasively analyze both LV wall motion and coronary flow, this imaging modality allows serial evaluation in the setting of transient cardiomyopathy such as LABS. As the patients described in this study did not present any flow-limiting LAD stenosis, CFR in this setting explores the microcirculation.21, 23 Adenosine acts substantially at the microcirculatory level, given that great epicardial arteries are relatively insensitive to this agent.26 Consequently, the variation of flow velocity recorded in the distal part of the LAD with adenosine is a surrogate marker of the variation of regional blood flow. Although the cut-off value of 2 for CFR is well documented to detect significant coronary stenosis or myocardial ischemia,22, 23 no cut-off value has been clearly defined when assessing microcirculation. However, comparison with the patient acting as his or her own control with serial measurements before and after an event can suggest a variation in microcirculatory disorders. Interestingly, the majority of patient (75%) had a CFR greater than or equal to 2 at the acute phase of LABS contrasting with the extent of WMA. However, the mean value of CFR was lower than what would be expected in patients without coronary artery disease.21 A significant increase of CFR was subsequently observed in all but one patient after the event had resolved. The CFR increased whereas LV wall motion improved, suggesting a relationship between WMA and microcirculatory impairment in the tako-tsubo syndrome. Illustrating this link, the correlation between delta WMS and delta WMSI and delta CFR, and between the extent of WMA at the acute phase and the change in CFR over time, despite the small sample size, was very significant. Interestingly, patient 4, who recovered very rapidly (within 48 hours), had one of the highest values of CFR at the acute phase and a less marked increase of CFR at follow-up. On the contrary, patient 12, who had extensive WMA and temporary mechanical support, had the lower CFR at the acute phase and the greater increase of CFR at follow-up, in parallel to total recovery of LV function. To our knowledge, this is the first study to assess the coronary microcirculation in LABS, particularly in a Caucasian population, using serial TTE-CFR measurements. Our results are in agreement with a recent Asian invasive study using a Doppler guidewire in the 3 coronary arteries of 8 patients,11 indicating that these two different populations share at least certain common pathophysiologic features of LABS. Improvement of hemodynamic factors and metabolic state27 or prescription of drugs with a favorable action on the coronary microcirculation could have influenced the increase of CFR at follow-up. However, although the heart rate decreased slightly, no significant change of the rate pressure product was observed between the two examinations and no differences could be observed concerning the prescription of major drugs such as beta-blockers, angiotensin-converting enzyme inhibitors, and statins before and after the event in the whole population. CFR increased at follow-up as hyperemic flow velocity was higher on the second test whereas baseline diastolic flow velocity remained unchanged, suggesting a blunted vasodilating capacity at the acute phase of the syndrome instead of a higher metabolic state as a cause of the lower initial CFR. The precise mechanism of the transient decrease of hyperemic coronary blood flow remains to be elucidated. Finally, serial noninvasive CFR measurements performed in these 12 patients with LABS suggested transient microcirculatory impairment during the acute phase of the syndrome. The wall-motion improvement parallel to the dynamic improvement of the CFR suggests a role of coronary microcirculatory damage in the pathogenesis of acute and transient WMA in LABS. References  1. 1Dote K, Sato H, Tateishi H, Uchida T, Ishihara M. Myocardial stunning due to simultaneous multivessel coronary spasm: a review of 5 cases. J Cardiol. 1991;21:203–214. MEDLINE 2. 2Tsutchihashi K, Ueshima K, Uchida T, Oh-mura N, Kimura K, Owa M, et al. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. J Am Coll Cardiol. 2001;38:11–18. Abstract | Full Text |
Full-Text PDF (1177 KB)
|
CrossRef
3. 3Kurisu S, Sato H, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, et al. Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J. 2002;143:448–455. Abstract | Full Text |
Full-Text PDF (187 KB)
|
CrossRef
4. 4Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol. 2003;41:737–742. Abstract | Full Text |
Full-Text PDF (511 KB)
|
CrossRef
5. 5Sharkey SW, Lesser JR, Zenovich AG, Maron MS, Lindberg J, Longe TF, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation. 2005;111:472–479.
CrossRef
6. 6Wittstein IS, Thiemann DR, Lima JAC, Baumghman KL, Schulman SP, Gerestenblith G, et al. Neurohormonal features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352:539–548.
CrossRef
7. 7Desmet WJR, Adriaenssens BFM, Dens JAY. Apical ballooning of the left ventricle: first series in white patients. Heart. 2003;89:1027–1031. 8. 8Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright S. Systematic review: transient left ventricular apical ballooning: a syndrome that mimic ST-segment elevation myocardial infarction. Ann Intern Med. 2004;141:858–865. 9. 9Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J. 2006;27:1523–1529.
CrossRef
10. 10Bybee KA, Prasad A, Barsness GW, Lerman A, Jaffe AS, Murphy JG, et al. Clinical characteristics and thrombolysis in myocardial infarction frame count in women with transient left ventricular apical ballooning syndrome. Am J Cardiol. 2004;94:343–346. Abstract | Full Text |
Full-Text PDF (245 KB)
|
CrossRef
11. 11Kume T, Akasaka T, Kawamoto T, Yoshitani H, Watanabe N, Neishi Y, et al. Assessment of coronary microcirculation in patients with takotsubo-like left ventricular dysfunction. Circ J. 2005;69:934–939. MEDLINE |
CrossRef
12. 12Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, et al. Myocardial perfusion and fatty acid metabolism in patients with tako-tsubo like left ventricular dysfunction. J Am Coll Cardiol. 2003;41:743–748. Abstract | Full Text |
Full-Text PDF (156 KB)
|
CrossRef
13. 13Ito K, Sugihara H, Kinoshita N, Azuma A, Matsubara H. Assessment of Takotsubo (ampulla) cardiomyopathy using 99mTc-tetrofosmin, 123 I-BMIPP, 123 I-MIBG, and 99mTc-PYP myocardial SPECT. Ann Nucl Med. 2005;19:435–445. MEDLINE |
CrossRef
14. 14Ako J, Takenaka K, Uno K, Nakamura F, Shoji T, Iijima K, et al. Reversible left ventricular systolic dysfunction: reversibility of coronary microvascular abnormality. Jpn Heart J. 2001;42:355–363. MEDLINE |
CrossRef
15. 15Upadya SP, Hoq SM, Pannala R, Alsous F, Tuohy E, Zarich S. Tako tsubo cardiomyopathy (transient left ventricular apical ballooning): case report of a myocardial perfusion echocardiogram study. J Am Soc Echocardiogr. 2005;18:883. Abstract | Full Text |
Full-Text PDF (212 KB)
|
CrossRef
16. 16Ramakrishna G, Ravi BS, Chandrasekaran K. Apical ballooning syndrome in a postoperative patient with normal microvascular perfusion by myocardial contrast echocardiography. Echocardiography. 2005;22:606–610. MEDLINE |
CrossRef
17. 17Citro R, Galderisi M, Maione AG, Inneli P, Provenza G, Gregorio G. Sequential transthoracic ultrasound assessment of coronary flow reserve in a patient with Tako-tsubo syndrome. J Am Soc Echocardiogr. 2006;19:. 18. 18Hozumi T, Yoshida K, Akasaka T, Asami Y, Ogata Y, Takagi T, et al. Non invasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol. 1998;32:1251–1260. Abstract | Full Text |
Full-Text PDF (246 KB)
|
CrossRef
19. 19Caiati C, Montaldo C, Zedda N, Montisci R, Ruscazio M, Lai G, et al. New non invasive method for coronary flow reserve assessment: contrast-enhanced transthoracic second harmonic echo Doppler. Circulation. 1999;99:771–778. MEDLINE 20. 20Meimoun P, Sayah S, Tcheuffa JC, Benali T, Luycx-Bore A, Levy F, et al. Transthoracic coronary flow velocity reserve assessment: comparison between dobutamine and adenosine. J Am Soc Echocardiograph. 2006;19:1220–1228. 21. 21Dimitrov PP, Galderisi M, Rigo F. The non-invasive documentation of coronary microcirculation impairment: role of transthoracic echocardiography. Cardiovasc Ultrasound. 2005;3:18. MEDLINE |
CrossRef
22. 22Meimoun P, Benali T, Sayah S, Luycx-Bore A, Boulanger J, Zemir H, et al. Evaluation of left anterior descending coronary artery stenosis of intermediate severity using transthoracic coronary flow reserve and dobutamine stress echocardiography. J Am Soc Echocardiogr. 2005;12:1233–1240. 23. 23Kern MJ. Coronary physiology revisited: practical insights from the cardiac catheterization laboratory. Circulation. 2000;101:1344–1351. 24. 24Shiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendation for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography committee on standards subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr. 1989;2:358–367. MEDLINE 25. 25Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet. 1986;99:771–778. 26. 26Sudhir K, MacGregor JS, Barbant SD, Foster E, Fitzgerald PJ, Chaterjee K, et al. Assessment of coronary conductance and resistance vessel reactivity in response to nitroglycerin, ergonovine, and adenosine: in vivo studies with simultaneous intravascular two-dimensional and Doppler ultrasound. J Am Coll Cardiol. 1993;21:1261–1268. Abstract |
Full-Text PDF (932 KB)
|
CrossRef
27. 27McGinn AL, White CW, Wilson RF. Interstudy variability of coronary flow reserve (Influence of heart rate, arterial pressure, and ventricular preload). Circulation. 1990;81:1319–1330. MEDLINE a Department of Cardiology and Intensive Care Unit, Compiègne Hospital, Compiègne, France b Department of Cardiovascular Disease, INSERM, ERI-12, CHU Amiens, Amiens, France. Reprint requests: Patrick Meimoun, MD, Department of Cardiology and Intensive Care Unit, Centre Hospitalier de Compiègne, 8 rue Henri Adnot, 60200 Compiègne, France.
PII: S0894-7317(07)00397-5 doi:10.1016/j.echo.2007.05.024 © 2008 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved. | |
|